{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:41:03Z","timestamp":1787920863747,"version":"build-2784847793"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008648","name":"Pfizer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaad.2019.06.025","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T11:14:21Z","timestamp":1560942861000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time"],"prefix":"10.1016","volume":"82","author":[{"given":"John S.","family":"Barbieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2019.06.025_bib1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.06.025_bib2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/bjd.15207","article-title":"Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin-associated pancreatitis","volume":"177","author":"Opel","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.06.025_bib3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2133.1993.tb03336.x","article-title":"Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests","volume":"129","author":"Barth","year":"1993","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.06.025_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000057887","article-title":"A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris","volume":"204","author":"Altman","year":"2002","journal-title":"Dermatol Basel Switz"},{"issue":"1","key":"10.1016\/j.jaad.2019.06.025_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2015.3091","article-title":"Laboratory monitoring during isotretinoin therapy for acne: a systematic review and meta-analysis","volume":"152","author":"Lee","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2019.06.025_bib6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archderm.142.8.1016","article-title":"A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris","volume":"142","author":"Zane","year":"2006","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.06.025_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaad.2016.03.019","article-title":"Standardized laboratory monitoring with use of isotretinoin in acne","volume":"75","author":"Hansen","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1 Suppl","key":"10.1016\/j.jaad.2019.06.025_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: a report from a Global Alliance to Improve Outcomes in Acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.06.025_bib9","author":"Optum, Inc"},{"key":"10.1016\/j.jaad.2019.06.025_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.diabres.2016.09.012","article-title":"Assessing occurrence of hypoglycemia and its severity from electronic health records of patients with type 2 diabetes mellitus","volume":"121","author":"Nunes","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jaad.2019.06.025_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijmedinf.2015.10.005","article-title":"Computer-assisted expert case definition in electronic health records","volume":"86","author":"Walker","year":"2016","journal-title":"Int J Med Inf"},{"issue":"3","key":"10.1016\/j.jaad.2019.06.025_bib12","first-page":"223","article-title":"Effects of GOLD-adherent prescribing on COPD symptom burden, exacerbations, and health care utilization in a real-world setting","volume":"2","author":"Mannino","year":"2015","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"5","key":"10.1016\/j.jaad.2019.06.025_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1684\/ejd.2015.2606","article-title":"Validating the diagnostic code for acne in a tertiary care dermatology centre","volume":"25","author":"Ejaz","year":"2015","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2019.06.025_bib15","series-title":"Clinical Laboratory Fee Schedule","year":"2018"},{"key":"10.1016\/j.jaad.2019.06.025_bib16","first-page":"CD005179","article-title":"Psychological interventions for needle-related procedural pain and distress in children and adolescents","volume":"10","author":"Birnie","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jaad.2019.06.025_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2015.09.046","article-title":"The use of oral antibiotics before isotretinoin therapy in patients with acne","volume":"74","author":"Nagler","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.06.025_bib18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jaad.2018.09.055","article-title":"Approaches to limit systemic antibiotic use in acne: systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments","volume":"80","author":"Barbieri","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.06.025_bib19","series-title":"Health Savings Accounts and High Deductible Health Plans Grow as Valuable Financial Planning Tools","year":"2018"},{"key":"10.1016\/j.jaad.2019.06.025_bib20","series-title":"Transparency in Pricing for the Hospital of the University of Pennsylvania","year":"2018"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219309892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219309892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:52:51Z","timestamp":1759272771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219309892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0190962219309892"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.06.025","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}